Samantha G Farris1, Adam M Leventhal2, Norman B Schmidt3, Michael J Zvolensky4. 1. Department of Psychology, University of Houston, Houston, Texas. 2. Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, California, Department of Psychology, University of Southern California, Los Angeles, California. 3. Department of Psychology, Florida State University, Tallahassee, Florida. 4. Department of Psychology, University of Houston, Houston, Texas, Department of Behavioral Science, The University of Texas MD Anderson Cancer Center, Houston, Texas.
Abstract
OBJECTIVE:Anxiety sensitivity appears to be relevant in understanding the nature of emotional symptoms and disorders associated with smoking. Negative-reinforcement smoking expectancies and motives are implicated as core regulatory processes that may explain, in part, the anxiety sensitivity-smoking interrelations; however, these pathways have received little empirical attention. METHOD: Participants (N = 471) were adult treatment-seeking daily smokers assessed for a smoking-cessation trial who provided baseline data; 157 participants provided within-treatment (pre-cessation) data. Anxiety sensitivity was examined as a cross-sectional predictor of several baseline smoking processes (nicotine dependence, perceived barriers to cessation, severity of prior withdrawal-related quit problems) and pre-cessation processes including nicotine withdrawal and smoking urges (assessed during 3 weeks before the quit day). Baseline negative-reinforcement smoking expectancies and motives were tested as simultaneous mediators via parallel multiple mediator models. RESULTS: Higher levels of anxiety sensitivity were related to higher levels of nicotine dependence, greater perceived barriers to smoking cessation, more severe withdrawal-related problems during prior quit attempts, and greater average withdrawal before the quit day; effects were indirectly explained by the combination of both mediators. Higher levels of anxiety sensitivity were not directly related to pre-cessation smoking urges but were indirectly related through the independent and combined effects of the mediators. CONCLUSIONS: These empirical findings bolster theoretical models of anxiety sensitivity and smoking and identify targets for nicotine dependence etiology research and cessation interventions.
RCT Entities:
OBJECTIVE:Anxiety sensitivity appears to be relevant in understanding the nature of emotional symptoms and disorders associated with smoking. Negative-reinforcement smoking expectancies and motives are implicated as core regulatory processes that may explain, in part, the anxiety sensitivity-smoking interrelations; however, these pathways have received little empirical attention. METHOD:Participants (N = 471) were adult treatment-seeking daily smokers assessed for a smoking-cessation trial who provided baseline data; 157 participants provided within-treatment (pre-cessation) data. Anxiety sensitivity was examined as a cross-sectional predictor of several baseline smoking processes (nicotine dependence, perceived barriers to cessation, severity of prior withdrawal-related quit problems) and pre-cessation processes including nicotine withdrawal and smoking urges (assessed during 3 weeks before the quit day). Baseline negative-reinforcement smoking expectancies and motives were tested as simultaneous mediators via parallel multiple mediator models. RESULTS: Higher levels of anxiety sensitivity were related to higher levels of nicotine dependence, greater perceived barriers to smoking cessation, more severe withdrawal-related problems during prior quit attempts, and greater average withdrawal before the quit day; effects were indirectly explained by the combination of both mediators. Higher levels of anxiety sensitivity were not directly related to pre-cessation smoking urges but were indirectly related through the independent and combined effects of the mediators. CONCLUSIONS: These empirical findings bolster theoretical models of anxiety sensitivity and smoking and identify targets for nicotine dependence etiology research and cessation interventions.
Authors: Adam Gonzalez; Michael J Zvolensky; Anka A Vujanovic; Teresa M Leyro; Erin C Marshall Journal: J Psychiatr Res Date: 2008-04-15 Impact factor: 4.791
Authors: David R Strong; Christopher W Kahler; Adam M Leventhal; Ana M Abrantes; Elizabeth Lloyd-Richardson; Raymond Niaura; Richard A Brown Journal: Nicotine Tob Res Date: 2009-07-02 Impact factor: 4.244
Authors: Charles Philip Brandt; Jafar Bakhshaie; Charles Jardin; Chad Lemaire; Brooke Y Kauffman; Carla Sharp; Michael J Zvolensky Journal: Int J Behav Med Date: 2017-02
Authors: Sarah A Bilsky; Matthew T Feldner; Ashley A Knapp; Sasha M Rojas; Ellen W Leen-Feldner Journal: Exp Clin Psychopharmacol Date: 2016-04-07 Impact factor: 3.157
Authors: Samantha G Farris; Angelo M DiBello; Nicholas P Allan; Julianna Hogan; Norman B Schmidt; Michael J Zvolensky Journal: Psychol Assess Date: 2015-04-20
Authors: Lisa R LaRowe; Kirsten J Langdon; Michael J Zvolensky; Emily L Zale; Joseph W Ditre Journal: Exp Clin Psychopharmacol Date: 2017-06-08 Impact factor: 3.157
Authors: Michael J Zvolensky; Lorra Garey; Nicolas P Allan; Samantha G Farris; Amanda M Raines; Jasper A J Smits; Brooke Y Kauffman; Kara Manning; Norman B Schmidt Journal: J Consult Clin Psychol Date: 2018-05
Authors: Samantha G Farris; Lisa A Uebelacker; Richard A Brown; Lawrence H Price; Julie Desaulniers; Ana M Abrantes Journal: J Behav Med Date: 2017-04-27
Authors: Lorra Garey; Emily T Hébert; Nubia A Mayorga; JeanFelix Chavez; Justin M Shepherd; Michael S Businelle; Michael J Zvolensky Journal: Br J Clin Psychol Date: 2021-05-03